In the world
Stago Group Companies
My Qualiris QCOur International External Quality Assessment (EQA) program for Hemostasis organized by a Proficiency Testing provider accredited to the ISO 17043 standard.
My Expert QCMy Expert QC was designed as part of a process of continuous improvement of quality control management. It enables users to compare their internal quality control results with those of their peers on any instrument of the STA range.
STA-NeoPTimal The website dedicated to the PT offer (STA-NeoPTimal) with unique performances to meet your productivity needs.
Stago webinarsStago provides you with the latest information regarding new tests, new markers or key assays for Thrombosis and Hemostasis. These educational sessions are provided by healthcare professionals and international key opinion leaders in the field.

Point of Care

The Stago group integrates a new Point-of-Care Viscoelastic testing system.

Diagnostica Stago recently acquired HemoSonics, a USA based company responsible for developing the Quantra® System, comprised of the Quantra Hemostasis Analyzer & QPlus® Cartridge.

This innovative in vitro diagnostic platform is designed to assess a patient’s coagulation status by measuring changes in viscoelastic properties of a blood sample during clot formation in surgical and intensive care setting.  The Quantra System is based on a patented technology, Sonic Estimation of Elasticity via Resonance (SEER*) Sonorheometry which uses high frequency ultrasound to measure the shear modulus (clot strength) of whole blood during coagulation.
A fully automated device, the Quantra analyzer is designed for use by clinical staff with no specialized training, requires less than 1minute hands-on time and provides easy to interpret actionable information to guide the management of critical bleeding in ≤ 15 minutes.

To explore publications and clinical studies on the QuantraOpens external link in current window click here.

* Sonic Estimation of Elasticity via Resonance.

Top